Opko Health Inc. OPK
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
OpKO Health Inc. is a multinational biopharmaceutical and diagnostics company operating through two primary segments: Pharmaceuticals and Diagnostics. In the Pharmaceuticals segment, it develops and commercializes therapies such as Rayaldee, FDA-approved for treating secondary hyperparathyroidism in adults with chronic…
SectorHealthcare
ExchangeNASDAQ
IndustryDiagnostics & Research
CountryUnited States
Employees2,275
TickerOPK
Statistics
Market Cap$1.06B
Revenue (TTM)$606.9M
Net Income-$225.7M
Net Margin-37.2%
EPS$-0.30
P/E-4.78
P/S1.88
P/B0.87
EV/EBITDA-10.24
ROE-16.9%
Dividend Yield—
Price$1.41
Data: Twelve Data · Revenue = mcap / P/S